Wun T C, Palmier M O, Siegel N R, Smith C E
Monsanto Co., Chesterfield, Missouri 63198.
J Biol Chem. 1989 May 15;264(14):7862-8.
Human Hep G2 hepatoma and HT 1080 fibrosarcoma cells were cultured in large scale under conditions which allowed enhanced secretion of plasminogen activator inhibitor-1 (PAI-1). A modified urokinase was obtained by reacting urokinase with phenylmethylsulfonyl fluoride followed by alkali treatment. The resulting product, called anhydrourokinase, was found to reversibly bind the PAI-1 when immobilized on cyanogen bromide-activated Sepharose 4B beads. Using this affinity absorbent, we have purified PAI-1 from the cell-conditioned media. A number of differences have been observed during Hep G2 and HT 1080 PAI purification. 1) The PAI activity in Hep G2 medium concentrate is more stable, and the concentrate depleted of active PAI-1 showed spontaneous regeneration of PAI-1 activity. In contrast, the PAI activity in HT 1080 medium concentrate declines rapidly on standing. 2) Hep G2 PAI-1 invariably copurified with an adhesive protein, vitronectin or its NH2-terminal fragment, while pure HT 1080 PAI-1 alone was obtained by affinity purification on anhydrourokinase-Sepharose 4B. 3) Based on specific activity measurement and complex formation analysis using a sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis technique, the purified Hep G2 PAI-1 appears completely active while the HT 1080 PAI-1 is only one-fourth as active. SDS was found to exert dual effects on purified PAI-1s. SDS treatment partially inactivated a fully active Hep G2 PAI-1 and a moderately active HT 1080 PAI-1 but partially activated an HT 1080 PAI-1 whose activity had previously been allowed to decay to a very low level. Purified vitronectin was found to enhance and stabilize the PAI-1 activity of the partially active HT 1080 PAI-1. It is concluded that fully active PAI-1 in association with vitronectin can be isolated by anhydrourokinase-Sepharose 4B chromatography and that vitronectin is a binding protein for PAI-1 which activates and stabilizes PAI-1.
人肝癌Hep G2细胞和纤维肉瘤HT 1080细胞在能增强纤溶酶原激活物抑制剂-1(PAI-1)分泌的条件下大规模培养。通过将尿激酶与苯甲基磺酰氟反应,然后进行碱处理,得到一种修饰的尿激酶。将所得产物称为无水尿激酶,发现其固定在溴化氰活化的琼脂糖4B珠上时可与PAI-1可逆结合。使用这种亲和吸附剂,我们从细胞条件培养基中纯化了PAI-1。在Hep G2和HT 1080的PAI纯化过程中观察到了一些差异。1)Hep G2培养基浓缩物中的PAI活性更稳定,去除活性PAI-1的浓缩物显示PAI-1活性可自发再生。相比之下,HT 1080培养基浓缩物中的PAI活性静置时迅速下降。2)Hep G2 PAI-1总是与一种黏附蛋白、玻连蛋白或其NH2末端片段共纯化,而通过在无水尿激酶-琼脂糖4B上进行亲和纯化可单独获得纯的HT 1080 PAI-1。3)基于比活性测量以及使用十二烷基硫酸钠(SDS)-聚丙烯酰胺凝胶电泳技术进行的复合物形成分析,纯化的Hep G2 PAI-1似乎完全有活性,而HT 1080 PAI-1的活性仅为其四分之一。发现SDS对纯化的PAI-1有双重作用。SDS处理使完全有活性的Hep G2 PAI-1和中等活性的HT 1080 PAI-1部分失活,但使活性先前已衰减至非常低水平的HT 1080 PAI-1部分活化。发现纯化的玻连蛋白可增强并稳定部分活性的HT 1080 PAI-1的PAI-1活性。得出的结论是,可通过无水尿激酶-琼脂糖4B色谱法分离与玻连蛋白结合的完全有活性的PAI-1,并且玻连蛋白是PAI-1的一种结合蛋白,可激活并稳定PAI-1。